Registration and Pricing

The American College of Clinical Pharmacology^® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact INFO@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

Requirements for Credits

All requirements for claiming CE credits are listed in the CE Info (Handout) tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.

CE Expiration 12/31/2026

2023 ACCP Webinar: From Exogenous Probes to Endogenous Biomarkers: A Paradigm Shift in the Approach to Assess Transporter Mediated Drug-Drug Interactions - ON DEMAND

Why is this Webinar important to you?

Membrane bound drug transporters, expressed in various tissues throughout the body, control the movement of endogenous and exogenous substances in and out of cells at various sites in the body.  Some drugs interact with transporters either as substrates or modulators (inhibitors or inducers), therefore, evaluation of transporter mediated drug-drug interactions (DDI) during drug development and post-approval is important to formulate clinical management strategies and ensure the safe and effective use of concomitantly administered drugs.  

 An integral part of a comprehensive clinical pharmacology program includes assessing the effect of an investigational drug on various transporters.  This assessment may be completed by either conducting several DDI trials (generally a trial for each transporter modulated by the investigational drug) or by conducting one trial to explore the effect of the investigational drug on the pharmacokinetics of several simultaneously administered (at therapeutic dose or microdose) probe drugs (“probe cocktail” approach). 

 More recently, the idea of assessing changes in the concentration of endogenous biomarkers (which are substrates of clinically relevant transporters) to gain insight on the potential of a drug to inhibit transporter activity has received widespread attention. Numerous publications and presentations by various investigators have highlighted how endogenous biomarkers can enable early “derisking” by assessing DDI potential over a wide range of inhibitor exposures, facilitate quantitative prediction of DDIs and provide mechanistic insights into observed DDIs. 

Target Audience

Physicians, Pharmacists, PhDs and other healthcare professionals interested in the evaluation of transporter-mediated DDIs during drug development and post-approval.

Learning Objectives

After completing this activity, the learner will be able to:

1. Learn how the transporter only probe cocktail trial approach has been used in drug development;
2. Explain the advantages and challenges of using microdose trials for assessment of transporter-mediated DDIs;
3. Describe the emerging role of endogenous biomarkers in the assessment of transporter-mediated DDIs;
4. Discuss how the assessment of endogenous biomarkers can be integrated in probe cocktail trials for comprehensive characterization of transporter-mediated DDI assessments.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Delivering an Effective Interview Presentation" | ON DEMAND

On Demand: October 25th, 2023 to October 25th, 2026

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on how to present an impactful scientific presentation and be well prepared for a robust Q&A as part of an interview process.

Learning Objective:

After completing this activity, the learner will be able to:

1. Discuss approaches for creating clear and concise presentation targets for the hiring audience and target position;
2. Learn and understand key strategies to engage and retain the target audience's interest;
3. Develop skills to approach Q&A sessions with confidence.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Key Expertise/Insight to Ace the Interview" | ON DEMAND

On Demand webinar: October 11th, 2023 to October 11th, 2026 

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on how to prepare for  and ace an interview to get the job you want!

Learning Objective:

After completing this activity, the learner will be able to:

1. Navigate etiquette expectations throughout introductions and the interview process;
2. Identify appropriate and inappropriate behaviors during the virtual and on-site job interview;
3. Formulate directed and meaningful questions and answers during the interview process.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Crafting a High Impact CV" | ON DEMAND

On Demand: September 20th, 2023 to September 20th, 2026

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on developing a high-quality, impactful CV that will get the attention of  HR and the hiring managers.

Learning Objective:

After completing this activity, the learner will be able to:

1. Discuss the employer's perspectives on the screening and hiring process;
2. Identify ways to develop and feature unique skills and experiences in a high impact CV based on targeted career goals;
3. Utilize professional and social platforms effectively.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: Achieving Career Resilience to Cherish Professional Success & Personal Fulfillment: A Fireside Chat with Karthik Venkatakrishnan, PhD & Beth Kennedy, MS, LMFT | ON DEMAND

On Demand: August 24th, 2023 to August 24th, 2026

Target Audience:

This webinar will be important to Students, Trainees & Early-stage Professionals seeking guidance from career coaches and successful professionals on how to apply critical tools to nurture trust, purpose and gratitude to achieve career resilience that empowers professional success and personal fulfillment.

Learning Objective:

After completing this activity, the learner will be able to:

1. Learn how to identify your Ikigai (your "Why") with Purpose Orientation;
2. Understand how to discover and nurture your brand;
3. Boost resilience by developing effective skills for time & energy management using the 4-Quadrant Theory.

2023 ACCP IDE Webinar: Engaging With the Community to Achieve Inclusivity, Equity & Diversity in Drug Development & Approval: Where to Start | ON DEMAND

On Demand webinar recording: August 23rd, 2023 to August 23rd, 2026

Why is this webinar important to your practice? 

Racially and ethnically diverse study participants have been frequently under-represented in clinical trials. Public health and optimal health outcomes among racially, ethnically and gender diverse populations require a closer look at clinical trial disparities and how to improve design and conduct of studies. Other unrepresented populations include people with obesity, physical and mental health conditions limiting their access to clinical trials, including pregnant people.This lack of diversity among clinical trials participants can lead to an inability to fully characterize the impact of important differences in pharmacokinetics, safety and efficacy profiles. Clinical trials are critical part of the drug development process prior to market approval and require time and significant financial and organizational investment.  When diversity is not accounted for during the clinical trial and recruitment, access to a drug upon approval may not be inclusive for all and equitable to the populations in need.

This webinar will focus on an overview of the importance to engage with the diverse community throughout clinical trials design and implementation. Attendees will be provided with concrete examples of the different approaches of engaging with the community for under-represented populations. Current initiatives of regulatory agencies and drug companies to include special populations in clinical trials will be presented and discussed. This session will enable the audience to gain practical perspectives from multiple stakeholders including patient advocates, drug developers, health care practitioners and regulators.

Target Audience:

Graduate students, post-doctoral fellows/trainees, early-stage and advanced professionals working in clinical trial design and implementation. 

Learning Objectives

After completing this activity, the learner will be able to:

1. Gain competence and improve performance to provide high quality care.

2. Increase evidence-based new medical knowledge.

3. Learn interdisciplinary educational strategies to improve patient safety and to facilitate patient-centered care.

2023 ACCP Virtual Journal Club Webinar: Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK-Informed Analysis | ON DEMAND

On Demand webinar recording: August 16th, 2023 to August 16th, 2026

Why is this article important to your practice? 

Venetoclax is an approved BCL-2 inhibitor that is primarily metabolized by cytochrome P450 3A (CYP3A). Although venetoclax exposure has been well characterized with one concomitant CYP3A inhibitor, complex drug-drug interactions involving more than one inhibitor have not been systematically evaluated despite the common polypharmacy in the target populations. In this webinar, the author will leverage physiologically-based pharmacokinetic (PBPK) and population pharmacokinetic (PK) modeling to describe the potential impact of multiple concomitant CYP3A inhibitors on venetoclax pharmacokinetics. The modeling approaches were informed by clinical data in the presence of single or multiple CYP3A inhibitors and the effects of one or more inhibitors were systematically evaluated within these modeling frameworks. Learners that complete this activity will be able to describe the potential impact of multiple concomitant CYP3A inhibitors on venetoclax pharmacokinetics using PBPK and population PK modeling.

Target Audience:

Physicians, Pharmacists, PhDs and other healthcare professionals interested in PBPK/PopPK modeling, drug-drug interactions.

Learning Objectives

After completing this activity, the learner will be able to:

1. Describe the rationale to assess and quantify the potential impact of multiple concomitant CYP3A inhibitors on venetoclax pharmacokinetics;
2. Describe the approaches and validation procedures used to inform dose adjustment for co-administration of venetoclax with multiple CYP3A inhibitors;
3. Describe the benefits and limitations of these approaches to identify the potential impact of multiple concomitant medications in the development of new agents.

2023 ACCP Student, Trainee & Early-stage Professional "Effectively Navigating the Mentee's Role in the Mentoring Journey" | ON DEMAND

On Demand webinar recording: May 31, 2023 to May 31, 2026

Target Audience:

This webinar will be important to Students, Trainees & Early-stage Professionals striving to develop relationships critical for career development and skills for self-awareness, leadership and problem solving. Attendees will learn how to develop and maintain successful mentoring relationships, build the network and resources to balance career with mental & emotional well-being, stay abreast of new developments and evolving technology and thrive in their careers.

Learning Objective:

After completing this activity, the learner will be able to:

1. Overcome fear, learn how to foster flexibility and effectively initiate mentorship-mentee relationships to meet needs that evolve over the various stages of career development;
2. Identify deficiencies and create a holistic approach by understanding the scope of professional and personal colleagues required to support your professional journey;
3. Fine tune skills for career planning and networking;
4. Learn how to “pay it forward” to the next generation of clinical pharmacologists.

ACCP 2023 Clinical Practice Webinar - Leveraging Novel Microbiome-related Therapies | ON DEMAND

On Demand webinar recording:  May 24, 2023 to May 24, 2026

Why is this article important to your practice? 

This clinical webinar will introduce the gut-brain axis including an overall perspective with relevant publications. The presentation will also discuss the link between the gut-brain, alcohol and other addiction (eating) disorders including examples of gut-brain-related neuroendocrine pathways (e.g., ghrelin, GLP-1) that may be relevant in the development of neuro-behavioral conditions such as addiction. Preliminary rat results will be presented from observations of binge-like alcohol drinking leading to changes in the gut microbiome in a manner independent from the presence or not (knock-out) of the ghrelin receptor. Additionally, results from a recently-published manuscript investigating the gut microbiome and metabolome of binge-drinking primates will be reviewed. Speakers will introduce an unpublished clinical protocol and will present preliminary gut microbiome data investigating the gut microbiome of abstinent and currently drinking individuals with alcohol use disorder (AUD) and controls.

Target Audience: 

Physicians, Pharmacists, PhDs and healthcare professionals interested in clinical pharmacology.

Learning Objectives: 

After completing this activity, the learner will be able to:

1. Identify the broad characterization of pathology associated with microbiome changes in several neurological conditions;

2. Estimate the correlations of microbial changes in neuro-behavioral statuses like eating disorders and AUD;

3. Assess why periodontitis is more common in AUD and compare the abundances of health- and periodontitis-associated previously identified genera to those in individuals with AUD;

4. Explore the influence of alcohol consumption and type of drinking and observe longitudinal-temporal changes in the oral microbiome in newly abstinent individuals undergoing inpatient treatment for AUD.